 Today we're talking to Christopher Eccleston who has just started his coverage of OXACO resources. He talks about how OXACO has a uniquely endowed project with exposure to rare earths, titanium, hafnium, and zircon. He also talks about exposure to tin. Is that correct? Absolutely. I had no idea. There was so much monocyte. How about we start there? Yeah. Who knew? Anyone who has known this stock for a long time sees from the name and from the history and they think it's a precious metal store. But in fact the company has done a total 180, if not a total 360, and is now a player and a real player, not just a talker, in the monocyte mark. The monocyte, of course, was not one of the trendy rare earth minerals back in the last boom. But this time around it's virtually the word on everyone's lips because while it does have the negative in some contexts of uranium and thorium, that issue seems to have become one that's somewhat moot. And so people just liking the fact that monocytes stand to scoop them up. You send them off to be processed and have the thorium removed. And then, hey, ho, you've suddenly got a rare earth concentrate without blasting, without having to go to the most isolated places in Nuremberg or wherever, the Greenland, dare I say, and you're in business. And so Oxico saw this. They've started off with a trading relationship in the DRC with their sister company, Central American, NECOR, where they're actually trading the metal for them. But they actually have an arrangement in Brazil, and they have their own property in Colombia, all of which are rich in monocyte sands. And so they've gone from being a nothing to being a player in a space where, you know, still most of the people are talkers and not doers. They've gone to being a player. I've told a few people over the last year and a half, I said, Oxico is a dark horse. Get them on, get them on your whiteboard. They're definitely a rare earth player. Can you tell us a little bit more about the surprises I was reading about the actual rare earth resource, which seems to be shockingly high for me, for for my experience. Can you tell us a little bit about the highlights of that? And then everybody, if you want to know, Christopher says buy or hold or sell, you've got to go to Helgaard and company and actually get this research report. So Christopher, talk to me a little bit about these highlights, because it surprised me the the actual numbers. Well, people tend to look at monocyte sands, not as little discrete deposits, but as enormous amounts of sand that have accumulated back millennia ago, if not millions of years ago, when rock was broken down and converted into sand. So when you're generally talking about monocyte sands, no matter where they might be or mineral sands, let's say, they tend to come in very large numbers. And the only limitation is how much you can scoop up and how much you can ship out and how much you can then sell. It's not an issue of having something really small in a really isolated location. And that is advantageous monocyte sands and why they're really sort of pushing their way in. For anyone who knows the genesis of this, it was really when the US company energy fuels suddenly decided it was going to start processing mineral sands from the US, converting them into concentrate, then sending them off to near performance materials refinery in Estonia. But once people saw that, saw that that worked, everyone said, Hey, we've got some monocyte sands. Well, I'm not even bothered that a few people had monocyte sands still, because no one had been trumpeting this mineralization, you know, as you well remember, back in the first boom, there were carbonitides, phosphocytes and these things. And monocyte was totally pushed to the side because, you know, radioactivity was a no no. But, you know, the marriage between KAMORS, the US chemical company and energy fuels in NEO showed that you can get the radioactivity out. So that is the side of the business that AUXICO, you know, plugging into because it had these large monocyte sands at their fingertips. And now they're monetized. In the case of the ones in the DRC, which they've they've merely got a trading relationship. So they actually market the product it's mined by artisanals. They're marketed to China, because the Chinese don't care about the radioactivity like you know, Western companies do. And so they've the Chinese will take it, they will remove the radioactivity, which then gives some material that they can use for their own nuclear industry. But the West is now turning around and saying, Hey, the Chinese are getting all this stuff. What can we do? We can plug into this. And so AUXICO had this large, what they thought was tin tailings operation in the backwoods of Brazil, over near the Bolivian border. And turns out there has a large monocyte component as well, long been overlooked, and large gone into tailings. So in their efforts to repossess the tin tailings and take advantage of the surge of tin price, they discovered, hey, we've got monocyte here as well. And so that is where we get the situation where this is great potential resource. And then, of course, they had their own property in Colombia on the border with Venezuela, but on the right side of that border. And that has proven to be a really exciting multi mineral deposit. So not only does it have the rarest, but it has what precious metals and other things like tantalum, specialty metals. It's really the monastic asset that AUXICO has is really like an eye-popping collection of metals, largely because it was created bizarrely by an asteroid crash into the earth many millions of years ago. So again, we have Helgarten Company. You're one of the best in the world of critical minerals, and you've initiated coverage. And if you want to find out, go to Christopher Eccleston's website, which is what, Christopher? www.helgartenco.com. That's H-A-L-L-G-A-R-D-E-N-C-O.com. You'll learn a lot.